EMA Total Non-Current Assets

Emera Incorporated Common Shares · Total Non-Current Assets

EMA logo

EMA Total Non-Current Assets

Latest reported$42.39B CAD
EMA Quarterly Non-Current Assets · CAD ($2.73B → $42.39B)
High-resolution chart · PNG

EMA total non-current assets history

Quarterly · CAD. Dates are reporting period ends; fiscal years can differ from calendar years.

Emera Incorporated Common Shares Total Non-Current Assets — Quarterly (CAD)
Period endingTotal Non-Current Assets (CAD)
42,393,360,000
29,817,926,000
40,395,054,000
39,777,000,000
38,556,000,000
39,630,000,000
39,263,000,000
36,701,000,000
36,561,000,000
36,822,000,000
35,772,000,000
26,331,769,200
26,279,524,000
34,833,000,000
34,846,000,000
34,454,000,000
32,278,000,000
30,949,000,000
31,108,000,000
23,987,290,600
29,217,000,000
29,180,000,000
29,056,000,000
29,608,000,000
29,561,000,000
21,069,308,321
22,638,133,796
29,197,000,000
28,493,000,000
28,556,000,000
29,482,000,000
27,913,000,000
27,857,000,000
26,960,000,000
26,245,000,000
25,854,000,000
26,425,000,000
26,638,000,000
26,710,000,000
25,897,000,000
8,909,800,000
9,159,200,000
9,416,700,000
9,040,900,000
8,580,700,000
8,545,200,000
8,385,800,000
8,137,300,000
7,884,100,000
7,879,400,000
7,715,500,000
7,025,000,000
7,006,100,000
6,814,600,000
6,596,200,000
6,532,700,000
6,491,000,000
5,945,700,000
5,930,300,000
5,836,500,000
5,587,200,000
5,572,100,000
5,546,600,000
5,034,700,000
4,917,200,000
4,630,700,000
4,571,600,000
4,552,400,000
4,553,600,000
4,679,200,000
4,587,600,000
4,218,800,000
3,910,800,000
3,748,100,000
3,602,700,000
3,574,000,000
3,630,400,000
3,730,900,000
3,557,700,000
3,555,300,000
3,552,100,000
3,579,000,000
3,604,700,000
3,631,800,000
3,682,400,000
3,623,700,000
3,612,200,000
3,603,000,000
3,628,600,000
3,621,700,000
3,543,700,000
3,616,900,000
3,622,400,000
3,682,600,000
3,576,200,000
3,604,200,000
3,577,900,000
3,634,600,000
3,625,000,000
2,860,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.